New anti-AB vaccine could help halt Alzheimer's progression, preclinical study finds

(University of South Florida (USF Health)) A preclinical study led by University of South Florida Health neuroscientists indicates that an antigen-presenting dendritic vaccine with a specific antibody response to oligomeric Aβ may be safer and offer clinical benefit in treating Alzheimer's disease. The vaccine uses immune cells known as dendritic cells loaded with a modified Aβ peptide as the antigen.